FDA Inspection 1267049 — Amicogen (China) Biopharm Co., Ltd.
The FDA completed an inspection of Amicogen (China) Biopharm Co., Ltd. on Mar 31, 2025 in Jining. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Mar 31, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Jining (China)